Similarly, bleomycin, a naturally derived glycopeptide that inhibits HR repair [62], induces the aforementioned ICD markers [63], thereby triggering the onset of ICD and leading to the induction of IFN-γ and a CD8+ T-cell-mediated immune response against tumor cells. The gene discussed is CD8A; the disease is neoplasm.